Several oral phosphodiesterase type 5 inhibitors are available for the treatment of erectile dysfunction (ED) and a number of trials have previously identified a patient preference for tadalafil over ...
Tadalafil was well-tolerated and no participants discontinued the study due to treatment-emergent adverse effects. The study was conducted at a single center in South Korea. Low-dose tadalafil ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback